Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
The leading players in the industry are ICE, Mitsubishi Tanabe Pharma and Daewoong Chemical, with revenue ratios of 18.00%, 14.20% and 13.25%. By region, the European region has the highest income, accounting for about 44.68 percent in 2018.
Market Analysis and Insights: Global Ursodeoxycholic Acid Market
In 2019, the global Ursodeoxycholic Acid market size was US$ 654.3 million and it is expected to reach US$ 1553.4 million by the end of 2026, with a CAGR of 12.5% during 2021-2026.
Global Ursodeoxycholic Acid Scope and Market Size
Ursodeoxycholic Acid market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Ursodeoxycholic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Ursodeoxycholic Acid market is segmented into
Synthetic UDCA
Extraction UDCA
Segment by Application, the Ursodeoxycholic Acid market is segmented into
Pharmacy
Health Products
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Ursodeoxycholic Acid market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Ursodeoxycholic Acid product introduction, recent developments, Ursodeoxycholic Acid sales by region, type, application and by sales channel.
The major companies include:
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
The leading players in the industry are ICE, Mitsubishi Tanabe Pharma and Daewoong Chemical, with revenue ratios of 18.00%, 14.20% and 13.25%. By region, the European region has the highest income, accounting for about 44.68 percent in 2018.
Market Analysis and Insights: Global Ursodeoxycholic Acid Market
In 2019, the global Ursodeoxycholic Acid market size was US$ 654.3 million and it is expected to reach US$ 1553.4 million by the end of 2026, with a CAGR of 12.5% during 2021-2026.
Global Ursodeoxycholic Acid Scope and Market Size
Ursodeoxycholic Acid market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Ursodeoxycholic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.
Segment by Type, the Ursodeoxycholic Acid market is segmented into
Synthetic UDCA
Extraction UDCA
Segment by Application, the Ursodeoxycholic Acid market is segmented into
Pharmacy
Health Products
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Ursodeoxycholic Acid Market Share AnalysisUrsodeoxycholic Acid market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Ursodeoxycholic Acid product introduction, recent developments, Ursodeoxycholic Acid sales by region, type, application and by sales channel.
The major companies include:
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhangshanbelling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
